Research and experimental development on natural sciences and engineering
BLUE WAVE THERAPEUTICS AS
Revenue 2024
NOK 789,000
Operating profit
NOK −1.6m
Equity
NOK 471,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.52
Equity ratio
27.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -206.2% | |
| Net margin (%%) | -219.7% | |
| Return on assets (%%) | -94.9% | |
| Likviditet | ||
| Current ratio | 1.52 | |
| Working capital | 583k | |
| Soliditet | ||
| Equity ratio (%%) | 27.5% | |
| Debt-to-equity ratio | 2.64 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.